[Control of insomnia using a new benzodiazepine: flunidazepam or Ro 5-4200 (Phase I: Initial investigation. Phase II: Controlled study)].
D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D004325:Dreams; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009567:Nitrazepam / Q000627:therapeutic use; D010919:Placebos; D012890:Sleep; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013997:Time Factors
D014151:Anti-Anxiety Agents; D010919:Placebos; D009567:Nitrazepam
Le contrôle de l'insomnie par une nouvelle benzodiazepine: le flunidavepam ou Ro 5-4200 (investigations princeps de phase I et contrôlée de phase II)